Chimeric antigen receptor (CAR) T cell is a novel approach, which utilizes anti-tumor
immunity for cancer treatment. As compared to the traditional cell-mediated immunity, CAR-T …

Recent reports on the impressive efficacy of chimeric antigen receptor (CAR)-modified T
cells against hematologic malignancies have inspired oncologists to extend these efforts for …

The advent of chimeric antigen receptor (CAR)-T cell immunotherapies has led to
breakthroughs in the treatment of hematological malignancies. However, their success in …

Recently, the US Food and Drug Administration (FDA) approved the first chimeric antigen
receptor T cell (CAR-T) therapy for the treatment CD19-positive B cell acute lymphoblastic …

Simple Summary Chimeric antigen receptor T cells (CAR T-cells) are engineered T cells that
target tumor-associated antigens. CAR T-cell therapy is a novel developed immunotherapy …

Chimeric antigen receptor (CAR) T-cell immunotherapy refers to an adoptive
immunotherapy that has rapidly developed in recent years. It is a novel type of treatment that …

In recent years, chimeric antigen receptor (CAR) T-cell therapy has become popular in
immunotherapy, particularly after its tremendous success in the treatment of lineage …

Chimeric antigen receptors (CARs) are a series of manufactured receptors that have the
capacity of binding to specific antigens expressed on surface of tumor cells. A CAR normally …

Chimeric antigen receptor (CAR) T-cell therapy entails the genetic engineering of a patient's
T-cells to express membrane spanning fusion receptors with defined specificities for tumor …

Chimeric antigen receptors (CARs) are artificial recombinant receptors that generally
combine the antigen-recognition domain of a monoclonal antibody with T cell activation …